Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Literature
1.
Gallardo A, Garcia-Valdecasas B, Murata P, Teran R, Lopez L, Barnadas A, Lerma E (2017) Inverse relationship between Ki67 and survival in early luminal breast cancer: confirmation in a multivariate analysis. Breast Cancer Res Treat. doi:10.​1007/​s10549-017-4486-z [Epub ahead of print]
2.
Polley M-YC, Leung SCY, Mcshane LM, Gao D, Hugh JC, Mastropasqua MG, Viale G, Zabaglo LA, Penault-Llorca F, Bartlett JMS, Gown AM, Symmans WF, Piper T, Mehl E, Enos RA, Hayes DF, Dowsett M, Nielsen TO (2013) An International Ki67 reproducibility study. J Natl Cancer Inst 105:1897–1906CrossRefPubMedPubMedCentral
3.
Metadata
Title
Questions about Ki67 staining in luminal breast cancer
Author
Kadri Altundag
Publication date
01-01-2018
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2018
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-017-4515-y

Other articles of this Issue 2/2018

Breast Cancer Research and Treatment 2/2018 Go to the issue

Clinical trial

Discrepancies between biomarkers of primary breast cancer and subsequent brain metastases: an international multicenter study

Clinical trial

Usefulness of abbreviated breast MRI screening for women with a history of breast cancer surgery

Brief Report

A need for biology-driven personalized radiotherapy in breast cancer

Preclinical study

The importance of early detection of calcifications associated with breast cancer in screening

Epidemiology

Monosomy 17 in potentially curable HER2-amplified breast cancer: prognostic and predictive impact

Clinical trial

Exercise following breast cancer: exploratory survival analyses of two randomised, controlled trials
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits